GlassScriptPhysician profile
William D Fuller
NPI 1598747065
$10,539.70
in general payments reported to CMS, 2019-2025
20 companies · $1,428 in 2025
The $1,428 reported for 2025 was more than what 77% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,133 · 2020: $1,388 · 2021: $18.90 · 2022: $34.18 · 2023: $190 · 2024: $348 · 2025: $1,428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,370 · Travel and Lodging: $504 · Education: $91.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,369.84 |
| Travel and Lodging | $503.82 |
| Education | $91.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,800.48 | 2019-2025 | |
| Medtronic, INC. | $1,107.24 | 2024-2025 | Signia, Sonicision, Ligasure |
| Covidien LP | $640.75 | 2019 | |
| Ethicon US, LLC | $295.11 | 2019-2024 | Vistaseal, Harmonic, Echelon Flex |
| Edwards Lifesciences Corporation | $172.60 | 2025 | Sapien 3 Ultra Resilia |
| Davol INC. | $170.15 | 2019-2025 | Phasix Mesh |
| Tela Bio, INC. | $52.79 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Shire North American Group INC | $38.79 | 2019 | |
| Boston Scientific Corporation | $36.31 | 2019-2025 | Cds - Mct/Cem Monitoring |
| Dendreon Pharmaceuticals LLC | $34.60 | 2019 | |
| Biotronik INC. | $25.86 | 2024 | Renamic Neo |
| Pfizer INC. | $25.16 | 2024 | |
| Vivus LLC | $23.63 | 2023 | Qsymia |
| Mannkind Corporation | $23.21 | 2020 | |
| Stryker Corporation | $20.64 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $16.56 | 2025 | Voquezna |
| Lilly USA, LLC | $15.21 | 2020 | |
| Baxter Healthcare | $15.19 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.96 | 2025 | |
| Medtronic USA, INC. | $11.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Fuller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.